Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug disposition in cystic fibrosis: progress in understanding pathophysiology and pharmacokinetics.

Literature DB >> 3324042

Drug disposition in cystic fibrosis: progress in understanding pathophysiology and pharmacokinetics.

J Prandota¹.

Abstract

Entities: Disease

Mesh：

Substances：
Vitamins

Year: 1987 PMID： 3324042

Source DB: PubMed Journal: Pediatr Infect Dis J ISSN： 0891-3668 Impact factor: 2.129

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

Review 1. Drug disposition in cystic fibrosis.

Authors: E Rey; J M Tréluyer; G Pons
Journal: Clin Pharmacokinet Date: 1998-10 Impact factor: 6.447

2. Tolerance, pharmacokinetics and efficacy of once daily amikacin for treatment of Pseudomonas aeruginosa pulmonary exacerbations in cystic fibrosis patients.

Authors: P Vic; S Ategbo; D Turck; M O Husson; E Tassin; G A Loeuille; A Deschildre; D Druon; J C Elian; C Arrouet-Lagandre; J P Farriaux
Journal: Eur J Pediatr Date: 1996-11 Impact factor: 3.183

3. Diuretic effect and disposition of furosemide in cystic fibrosis.

Authors: J Prandota; I J Smith; B C Hilman; J T Wilson
Journal: Eur J Clin Pharmacol Date: 1991 Impact factor: 2.953

Review 4. Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors: J Prandota
Journal: Drugs Date: 1988-05 Impact factor: 9.546

5. Pharmacokinetics of Continuous Infusion Beta-lactams in the Treatment of Acute Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis.

Authors: Lisa T Hong; Theodore G Liou; Rishi Deka; Jordan B King; Vanessa Stevens; David C Young
Journal: Chest Date: 2018-06-13 Impact factor: 9.410

6. Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers.

Authors: J B Bulitta; S B Duffull; M Kinzig-Schippers; U Holzgrabe; U Stephan; G L Drusano; F Sörgel
Journal: Antimicrob Agents Chemother Date: 2007-05-07 Impact factor: 5.191

Drug disposition in cystic fibrosis: progress in understanding pathophysiology and pharmacokinetics.

Review 1. Drug disposition in cystic fibrosis.

2. Tolerance, pharmacokinetics and efficacy of once daily amikacin for treatment of Pseudomonas aeruginosa pulmonary exacerbations in cystic fibrosis patients.

3. Diuretic effect and disposition of furosemide in cystic fibrosis.

Review 4. Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

5. Pharmacokinetics of Continuous Infusion Beta-lactams in the Treatment of Acute Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis.

6. Systematic comparison of the population pharmacokinetics and pharmacodynamics of piperacillin in cystic fibrosis patients and healthy volunteers.

Review 7. Abnormal pharmacokinetics: the need for monitoring.

Review 8. Fluoroquinolones in the treatment of cystic fibrosis: a critical appraisal.

Review 9. Lean body mass as a predictor of drug dosage. Implications for drug therapy.

Review 10. Clinical pharmacokinetics in infants and children. A reappraisal.